Price to Earnings (P/E)
since 2005
Calculation
Gilead Sciences Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss) attributable to Gilead1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 16.45 | = | 70.10 | ÷ | 4.26 | 4.26 | = | 5,386 | ÷ | 1,263,636,656 | |
| Dec 31, 2018 | 15.26 | = | 65.28 | ÷ | 4.28 | 4.28 | = | 5,455 | ÷ | 1,275,510,558 | |
| Dec 31, 2017 | 22.75 | = | 80.36 | ÷ | 3.53 | 3.53 | = | 4,628 | ÷ | 1,309,967,781 | |
| Dec 31, 2016 | 6.83 | = | 70.50 | ÷ | 10.33 | 10.33 | = | 13,501 | ÷ | 1,307,066,900 | |
| Dec 31, 2015 | 6.75 | = | 89.36 | ÷ | 13.25 | 13.25 | = | 18,108 | ÷ | 1,366,845,691 | |
| Dec 31, 2014 | 12.85 | = | 104.43 | ÷ | 8.12 | 8.12 | = | 12,101 | ÷ | 1,489,401,683 | |
| Dec 31, 2013 | 42.00 | = | 83.95 | ÷ | 2.00 | 2.00 | = | 3,075 | ÷ | 1,538,252,914 | |
| Dec 31, 2012 | 25.20 | = | 42.89 | ÷ | 1.70 | 1.70 | = | 2,592 | ÷ | 1,522,392,518 | |
| Dec 31, 2011 | 12.20 | = | 22.58 | ÷ | 1.85 | 1.85 | = | 2,804 | ÷ | 1,514,630,722 | |
| Dec 31, 2010 | 10.68 | = | 19.49 | ÷ | 1.82 | 1.82 | = | 2,901 | ÷ | 1,590,529,288 | |
| Dec 31, 2009 | 16.29 | = | 23.76 | ÷ | 1.46 | 1.46 | = | 2,636 | ÷ | 1,806,757,972 | |
| Dec 31, 2008 | 20.29 | = | 22.40 | ÷ | 1.10 | 1.10 | = | 2,011 | ÷ | 1,821,909,204 | |
| Dec 31, 2007 | 25.19 | = | 21.90 | ÷ | 0.87 | 0.87 | = | 1,615 | ÷ | 1,857,740,064 | |
| Dec 31, 2006 | — | = | 17.65 | ÷ | -0.64 | -0.64 | = | -1,190 | ÷ | 1,858,655,664 | |
| Dec 31, 2005 | 34.15 | = | 15.03 | ÷ | 0.44 | 0.44 | = | 814 | ÷ | 1,849,138,544 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Gilead Sciences Inc.’s Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/E, long-term trends, comparison to competitors
| Gilead Sciences Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 16.45 | 41.83 | 17.82 | 17.07 | 41.99 | 16.19 | 43.43 | 25.99 | 20.60 | 11.63 | 19.86 | 52.90 | 45.89 |
| Dec 31, 2018 | 15.26 | 56.47 | 20.60 | 14.01 | 16.81 | 39.13 | 52.00 | 23.74 | 33.46 | 21.58 | 18.17 | 22.59 | 28.68 |
| Dec 31, 2017 | 22.75 | 220.29 | 35.47 | 64.06 | 103.55 | — | 44.63 | 268.10 | 61.63 | 9.99 | 28.99 | 155.08 | 44.09 |
| Dec 31, 2016 | 6.83 | 55.16 | 16.54 | 16.03 | 20.56 | 32.39 | 52.01 | 20.08 | 46.14 | 28.10 | 42.64 | — | 31.63 |
| Dec 31, 2015 | 6.75 | 12.83 | 17.01 | 15.95 | 64.22 | 33.35 | 50.07 | 18.80 | 31.64 | 26.37 | 60.50 | — | 62.14 |
| Dec 31, 2014 | 12.85 | 31.30 | 55.08 | 22.96 | 49.80 | 33.06 | 80.83 | 17.15 | 13.94 | 23.03 | 118.44 | — | 39.59 |
| Dec 31, 2013 | 42.00 | 23.25 | 19.64 | 18.69 | 35.01 | 13.88 | 174.33 | 18.72 | 37.83 | 9.32 | 77.00 | — | 29.02 |
| Dec 31, 2012 | 25.20 | 9.24 | 11.51 | 15.68 | 30.56 | 14.99 | 39.96 | 19.64 | 20.94 | 13.51 | 21.42 | — | 38.30 |
| Dec 31, 2011 | 12.20 | 18.67 | — | 14.61 | 15.07 | 10.42 | 72.33 | 18.48 | 18.63 | 15.99 | — | 267.42 | — |
| Dec 31, 2010 | 10.68 | 15.68 | — | 10.53 | 13.99 | 7.86 | 70.92 | 12.23 | 116.63 | 18.63 | — | — | — |
| Dec 31, 2009 | 16.29 | 14.69 | — | 12.10 | 4.03 | 9.18 | 60.45 | 14.22 | 9.00 | 16.41 | — | — | — |
| Dec 31, 2008 | 20.29 | 17.11 | — | 12.06 | 7.68 | — | 77.14 | 11.67 | 6.53 | 10.25 | — | — | — |
| Dec 31, 2007 | 25.19 | 23.82 | — | 15.64 | 20.60 | 19.26 | — | 17.07 | 29.88 | 18.51 | — | — | — |
| Dec 31, 2006 | — | 48.17 | — | 25.43 | 34.64 | 22.40 | 50.48 | 17.02 | 21.57 | 9.18 | — | — | — |
| Dec 31, 2005 | 34.15 | 20.03 | — | 23.70 | 14.96 | 31.90 | — | 16.95 | 16.62 | 23.92 | — | — | — |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Gilead Sciences Inc., P/E, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Gilead Sciences Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 16.45 | 21.51 |
| Dec 31, 2018 | 15.26 | 23.71 |
| Dec 31, 2017 | 22.75 | 38.05 |
| Dec 31, 2016 | 6.83 | 21.33 |
| Dec 31, 2015 | 6.75 | 19.24 |
| Dec 31, 2014 | 12.85 | 21.98 |
| Dec 31, 2013 | 42.00 | 19.69 |
| Dec 31, 2012 | 25.20 | 16.80 |
| Dec 31, 2011 | 12.20 | 16.77 |
| Dec 31, 2010 | 10.68 | 16.01 |
| Dec 31, 2009 | 16.29 | 11.66 |
| Dec 31, 2008 | 20.29 | 12.77 |
| Dec 31, 2007 | 25.19 | 20.58 |
| Dec 31, 2006 | — | 18.29 |
| Dec 31, 2005 | 34.15 | 20.86 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Industry (Health Care)
Gilead Sciences Inc., P/E, long-term trends, comparison to industry (health care)
| Gilead Sciences Inc. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 16.45 | 23.31 |
| Dec 31, 2018 | 15.26 | 25.51 |
| Dec 31, 2017 | 22.75 | 35.65 |
| Dec 31, 2016 | 6.83 | 22.95 |
| Dec 31, 2015 | 6.75 | 20.83 |
| Dec 31, 2014 | 12.85 | 22.58 |
| Dec 31, 2013 | 42.00 | 19.63 |
| Dec 31, 2012 | 25.20 | 17.46 |
| Dec 31, 2011 | 12.20 | 16.21 |
| Dec 31, 2010 | 10.68 | 16.26 |
| Dec 31, 2009 | 16.29 | 12.70 |
| Dec 31, 2008 | 20.29 | 14.16 |
| Dec 31, 2007 | 25.19 | 20.89 |
| Dec 31, 2006 | — | 20.98 |
| Dec 31, 2005 | 34.15 | 22.02 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).